Orange Book product · Brand (NDA)
SEGLENTIS
CELECOXIB; TRAMADOL HYDROCHLORIDE
At a glance
Oct 15, 2021
Approved
Brand (NDA)
Application
Not listed
TE code
7
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Oct 15, 2021
4 yr 9 mo ago
Today
Patent 10238668 expires
Listed drug substance patent expiration.
Apr 19, 2030
in 3 yr 11 mo
Patent 10245276 expires
Listed drug substance patent expiration.
Apr 19, 2030
in 3 yr 11 mo
Patent 10548909 expires
Listed method-of-use patent (U-3244) expiration.
Apr 19, 2030
in 3 yr 11 mo
Patent 11478488 expires
Listed method-of-use patent (U-3244) expiration.
Apr 19, 2030
in 3 yr 11 mo
Patent 8598152 expires
Listed drug substance patent expiration.
Apr 19, 2030
in 3 yr 11 mo
Patent 9012440 expires
Listed drug substance patent expiration.
Apr 19, 2030
in 3 yr 11 mo
Patent 8846744 expires
Listed drug product patent expiration.
Jun 03, 2031
in 5 yr
Pharmaceutical detail
Active ingredient
CELECOXIB; TRAMADOL HYDROCHLORIDE
Strength
56MG;44MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 213426
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (7)
| Patent | Expires | In | Type |
|---|---|---|---|
| 10238668 | Apr 19, 2030 | in 3 yr 11 mo | SubstanceProductU-3244 |
| 10245276 | Apr 19, 2030 | in 3 yr 11 mo | SubstanceProduct |
| 10548909 | Apr 19, 2030 | in 3 yr 11 mo | U-3244 |
| 11478488 | Apr 19, 2030 | in 3 yr 11 mo | U-3244 |
| 8598152 | Apr 19, 2030 | in 3 yr 11 mo | SubstanceProduct |
| 9012440 | Apr 19, 2030 | in 3 yr 11 mo | SubstanceProduct |
| 8846744 | Jun 03, 2031 | in 5 yr | Product |
